Skip to Main Content

++

  • Vasculitis associated with mixed cryoglobulinemia (MC) involves both small- and medium-sized vessels. The skin is the most commonly involved organ.
  • Other frequently affected organs include the joints, peripheral nerves, and kidneys. The central nervous system, gastrointestinal tract, and lungs are involved rarely or very rarely in MC.
  • Virtually all patients are rheumatoid factor (RF) positive.
  • Lower survival rates are observed with age over 60 years, male sex, and renal involvement.

++

Cryoglobulins are immunoglobulins (Ig) that precipitate from the serum at low temperatures (see method of collection under Laboratory Findings). Cryoprecipitates are composed most commonly of IgG and IgM (either singly or, in the case of mixed cryoglobulinemia, together). Occasionally IgA may be associated with clinically relevant cryoglobulin syndromes, as well. Cryoglobulinemia is divided into three clinical subsets—Types I, II, and III (Table 36–1)—based on two features: the clonality of the IgM component and the presence of RF activity. RF activity, by definition, is the reactivity of an IgM component with the Fc portion of IgG. This chapter focuses on cryoglobulinemia types II and III. (Type I cryoglobulinemia is usually not “mixed,” being associated with only a monoclonal IgG or IgM in the setting of a malignancy.)

++
Table Graphic Jump Location
Table 36–1. Types of Cryoglobulinemia.
++

Formerly referred to as “essential” MC, hepatitis C virus (HCV) infections are now known to be associated with approximately 90% of all cases of MC. Latency periods of up to 15 years between the occurrence of HCV infection and the development of clinical signs of MC have been reported. In some cases, the presentation of HCV may be the development of the clinical features of MC (usually palpable purpura). Cryoglobulins also occur in the setting of other types of infections as well as in connective tissue disorders (eg, Sjögren syndrome) and hematopoietic malignancies.

++

The presence of cryoglobulins is not always associated with clinical disease, but these proteins may result in a wide variety of immune complex–mediated complications. The term “mixed cryoglobulinemia” was coined to differentiate types II and III (both of which contain mixtures of both IgG and IgM) from type I (which contains only a single monoclonal antibody).

++

When an underlying infection, autoimmune disorder, or malignancy can be identified, the preferred treatment approach is to direct therapy toward the underlying condition. B cell depletion strategies are often coupled with antiviral therapies in patients with HCV-associated cryoglobulinemia. Occasionally, in patients with rampant systemic vasculitis, generalized immunosuppression or measures designed to remove immune complexes (ie, plasma exchange) ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.